T3D Therapeutics
Mr. Keim is Sr. Vice President and General Counsel for Global Corporate Affairs at SAS Institute Inc. SAS is a leading multi-national business analytics firm headquartered in Cary, NC, with offices in 50 countries. Mr. Keim joined SAS’s Legal Division in 1998. He manages an extensive team of legal professionals providing the company and its affiliates with guidance and advice in all areas of commercial law.
Mr. Keim serves as a member of the Board of Trustees of Gardner-Webb University, his undergraduate alma mater. He received a J.D. degree from Regent University School of Law (1990) and an LL.M. (Taxation) degree from the Marshall-Wythe School of Law at The College of William & Mary (1992).
Mr. Keim is also an Adjunct Professor of Law at the University of North Carolina School of Law in Chapel Hill, NC.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
T3D Therapeutics
T3D Therapeutics’ mission is to develop its lead drug product candidate, T3D-959, as a potential ‘First-in-Class’ and ‘Best-in-Class’ disease-modifying, breakthrough medicine for the treatment of Alzheimer’s disease with the potential to slow, stop or reverse the course of the disease.